Stock price when the opinion was issued
This company does sterilization equipment and they just got FDA approval. The stock didn’t do anything for 4 or 5 years, and have now done extremely well. Thinks they will be able to deploy this in many hospitals globally. Over the next few quarters, as more and more people see the company, the stock should continue to do well.
This has really interesting technology. They build sterilization units. The recent move in the stock from $2.20 to $3.70 was because they got FDA approval for using their technology in a new area that the market didn’t expect. They’ve just started commercially shipping these units. They get a price for their units, but they also get a recurring revenue from the consumables, such as trays, etc. A great business model if they can get into enough hospitals and locations. They have a reselling partner that is committed to about 100 units of the sterilizers, and the market is expecting that to ramp up to multi-hundreds over the next few years. If this continues to work, it has a long runway to go.
He exited the story and has not gotten back in. He felt it had had quite a run up and then there was a sell-through issue. He did not know how many sterilizers actually went into hospitals for sterilization. With FDA approval it should put lights and fire under the stock. It is not cheap especially when you don’t have revenue metrics.
If you are a hospital and need to sterilize some exotic equipment, the advantage of this company’s product is that it will do it very quickly and very economically. The equipment uses a combination of hydrogen peroxide in a cabinet, where you can put in unusual shaped objects. Recently got FDA approval. Also, they are using their old methodology for another kind of application. There is a definite need for their product. Forecasted earnings for 2017 is only $.02, so a lot of the good news has already been discounted. Not cheap.